Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...

You can see it coming in right there, that little spot,” says neuroscientist and engineer Laura Lewis. A remarkably bright pulsing dot has appeared on the monitor in front of us. We are watching, in ...

Genentech is continuing its summer of downsizing and cost-cutting, this time with plans to terminate a cell therapy deal worth as much as $2 billion. The pact is with Adaptive Biotechnologies and ...

10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...

HOUSTON – A new law passed by the Texas Legislature bans the use of cell phones and other personal communication devices in public schools during the school day. The law, which took effect last month, ...

Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected operations and key clinical milestones through at ...

All fruits have healthy nutrients in them, but berries are especially rich in flavonoids, plant compounds that are thought to benefit and protect the brain. A specific type called anthocyanins has ...

The glycocalyx surrounds each cell in the human body like a coat. This complex sugar layer plays a key role in the progression of numerous diseases, such as cancer and autoimmune diseases. The ...

The federal government is looking for researchers who can, in 5 years, develop stem cell treatments to repair brain damage caused by stroke, neurodegeneration, and trauma. The Functional Repair of ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook The connection between Superman and Kryptonite is so firmly established in American culture that ...

Bispecific T cell engagers (TcEs) are immunotherapeutic drugs that trigger the destruction of cancer cells by linking T cells to cancer cells through specific surface molecules (antigens). We designed ...